Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 14.0B | 15.6B | 15.7B | 16.7B |
| Cost of revenue | 11.0B | 11.1B | 11.5B | 11.5B |
| Gross profit | 3.0B | 4.4B | 4.1B | 5.1B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 676M | 1.0B | 963M | 1.2B |
| Other operating expenses | 1.8B | 1.7B | 1.8B | 1.7B |
| Operating income | 569M | 1.7B | 1.4B | 2.3B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 179M | 180M | 173M | 188M |
| Other income expense | -70M | -335M | 337M | -306M |
| Pretax income | 320M | 1.2B | 1.6B | 1.8B |
| Tax provision | 80M | 359M | 289M | 468M |
| Net income | 240M | 843M | 1.3B | 1.3B |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | 539M | 1.6B | 1.4B | 2.2B |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |